Jeffrey Curtis

[Dr. John Cush @RheumNow]

In Dec 2025, the FDA qualified total hip bone mineral density (BMD) assessed by DXA as a validated surrogate endpoint for osteoporosis clinical trials. Previously OP trials required fracture endpoints as primary efficacy measures, necessitating large 2-5 yr studies https://t.co/qxpMxHIFU6

[Dr. John Cush @RheumNow]

A&R USA adult rheum workforce study showed in 2019, there were 5,667 rheumatologists & 379 APPs. Betw 2009 - 2020, rheumatologist #s increased 23%, while #APP #s increased 141%. There was a signif increase in female rheumatologists & APPs over time https://t.co/Y5ZSwPLsNe

[Healio Rheumatology @HealioRheum]

📢 “We found that with the approaches that we used, we were able to achieve about 90% accuracy to classify #rheumatoidarthritis patients starting a new treatment as to whether they were in LDA,” said Dr. Jeffrey Curtis @RADoctor.

https://t.co/AlUwf8J6BU

[Mrinalini Dey @DrMiniDey]

Did you miss #TheGreatDebate on #ArtificialIntelligence at #ACR25?

Join Dr Jinoos Yazdany, @RADoctor and I as we take a whistlestop tour of highlights from the debate, and key points on #AI from convergence.

@RheumNow

https://t.co/CItSCWszHt

[Jeffrey Curtis @RADoctor]

As another #ACR25 Convergence draws to a close, the nontraditional conference badge engendered much discussion. Top picks were Optimistic, Disruptive, and Salty. Which are you?
Most fun is when others disagree and pick something else for you. @RheumNow #KnowThyself

[Jeffrey Curtis @RADoctor]

@drdavidliew delivers a terrific review of the role of #AI in #ILD identification, prognosis and outcomes at #ACR2025.
Will we need specialist trained models or will general purpose omnimodels (think #Gemini #nanobanana ) soon be good enough? https://t.co/wLiU4DSxmm #rheumnow

[David Liew @drdavidliew]

In the #ACR25 Great AI Debate, @RADoctor and @JYazdanyMD prepared independently, but in consecutive moments agree (in a very illustrative way):

guardrails - they need to happen

@RheumNow

[David Liew @drdavidliew]

In the #ACR25 Great AI debate, @RADoctor shows automated ultrasound scanning - one legitimately promising application ready very soon.

I’ve written about this work (ARTHUR/DIANA) for @RheumNow last year - check it out:
https://t.co/Zq4ywEjspi

[Jeffrey Curtis @RADoctor]

#AI isn’t coming for your job—it’s coming to join your care team. Excited to explore today how AI is reshaping the future of medicine with California’s top #rheumatology providers at @CalRheum. #AI #MedTech #RheumCare

[Brennan Spiegel, MD, MSHS @BrennanSpiegel]

The FDA just completed its first AI-assisted scientific review—marking a historic shift in how new therapies are evaluated. Tasks that took days now take minutes. An AI revolution is underway inside the agency.

If this is the start, what’s next? ⚖️🤖💊 https://t.co/qklOlWAWGe

[Jeffrey Curtis @RADoctor]

@RheumNow Amazing that GLP-1 drug spending now eclipses #adalimumab and other treatments for #rheumatoidarthritis #RA and #psoriaticarthritis #psoriasis. How many patients might benefit from both to treat the cardiometabolic manifestations of #rheum diseases and associated multimorbidity?

[Dr. John Cush @RheumNow]

US- Top Drug Rx Sales in 2024
Semaglutide $54 Billion
Tirzepatide $31.7 B
Adalimumab $28B
Apixaban $26 B
Empagliflozin $20.5 B
Pembrolizumab $18 B
Ustekinumab $17 B
Risankizumab $16 B
Dupilumab $15.6 B
Etanercept $10.1 B
Secukinumab $7.7 B
Immune globulin $7.1 B
Upadacitinib $7 B
Ixekizumab $5.8 B
Guselkumab $5.8 B https://t.co/ptP5kl1Tza

[ACR_Journals @ACR_Journals]

This week in A&R

TMP-SMX significantly reduces risk of serious infections in AAV patients receiving RTX or CYC induction therapy
https://t.co/OO2e95uAnv

No evidence of increased CV events during 1st 2 years of JAKi use vs TNFi in RA patients
https://t.co/qtuPpn21qV

[American College of Rheumatology @ACRheum]

NEW! Can #AI improve how we diagnose, treat, & monitor #rheum patients? In our latest episode, we explore AI’s growing role in #rheum & where it’s taking us next with @RADoctor. Listen HERE → https://t.co/yydtuaY2a4

[Jeffrey Curtis @RADoctor]

@KDAO2011 @RheumNow All the things that doctors do in the right column will never be replaced by #AI ! Most aspects of care embody what it means to be a doctor much more than merely answering board questions correctly.

[Jeffrey Curtis @RADoctor]

Great talk at #RNL2025 by Dr Una Makris on managing geriatric rheumatology patients.
How often do we under-treat #Rheumatoid arthritis patients with advanced therapies because we fall into the trap of ageism?

[Jeffrey Curtis @RADoctor]

Privileged to be at #CSRO discussing how generative and predictive #AI can support #rheumatology in value based care and reimbursement and its potential pitfalls. Fantastic group of people advocating for our field and especially our patients. #VBR #VBC @CSROAdvocacy

[David Liew @drdavidliew]

RA patients on abatacept have an appalling immunogenic response to Shingrix. Humoral fades away in the first year, and an absence of cellular responses.

Alarming and need strategies to combat this #EULAR2024 POS0620 Winthrop/@RADoctor @RheumNow

[Jeffrey Curtis @RADoctor]

Great talk by Dr Skip Rizzo alongside many others at #vMed24 describing how to increase the rigor of designing trials of medical extended reality (MXR) interventions in diverse healthcare settings to improve patient outcomes and increase wellness.

[Jeffrey Curtis @RADoctor]

Very appreciative to STAR Texas #rheumatology for their kind invitation to discuss new #covid19 and #shingles #vaccine data and how to overcome vaccine hesitancy! Thankful to be included in such an august cadre of speakers this weekend.